Philip Poole‐Wilson

2.8k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

Philip Poole‐Wilson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philip Poole‐Wilson has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philip Poole‐Wilson's work include Heart Failure Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac pacing and defibrillation studies (6 papers). Philip Poole‐Wilson is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac pacing and defibrillation studies (6 papers). Philip Poole‐Wilson collaborates with scholars based in United Kingdom, United States and Sweden. Philip Poole‐Wilson's co-authors include Michel Komajda, John G.F. Cleland, Marco Metra, Karl Swedberg, Andrew Charlesworth, Christian Torp‐Pedersen, Lars Olsson, Peter Hanrath, Dirk J. van Veldhuisen and Luigi Tavazzi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Philip Poole‐Wilson

31 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered Intestinal Function in Patients With Chronic Heart Failure

2007 501 citations Anja Sandek, Juergen Bauditz et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Poole‐Wilson United Kingdom	17	1.4k	308	237	222	219	31	2.1k
Niamh Murphy Ireland	21	1.7k 1.2×	154 0.5×	100 0.4×	703 3.2×	231 1.1×	60	2.7k
Yuji Nagatomo Japan	19	982 0.7×	273 0.9×	209 0.9×	193 0.9×	223 1.0×	130	1.5k
Kumudha Ramasubbu United States	19	1.8k 1.3×	385 1.3×	178 0.8×	199 0.9×	476 2.2×	47	2.9k
Katarina Eeg‐Olofsson Sweden	29	581 0.4×	349 1.1×	216 0.9×	64 0.3×	652 3.0×	85	2.5k
S Björck Sweden	26	983 0.7×	141 0.5×	179 0.8×	254 1.1×	523 2.4×	84	2.5k
Arnljot Tveit Norway	25	1.3k 0.9×	178 0.6×	111 0.5×	149 0.7×	303 1.4×	119	2.1k
Theodore D. Mountokalakis Greece	25	987 0.7×	102 0.3×	273 1.2×	123 0.6×	435 2.0×	37	1.9k
Jarosław Dróżdż Poland	21	1.9k 1.3×	134 0.4×	99 0.4×	394 1.8×	342 1.6×	136	2.3k
Elaine Cornell United States	17	611 0.4×	143 0.5×	187 0.8×	212 1.0×	192 0.9×	21	1.7k
Rekha Garg United States	17	1.4k 1.0×	140 0.5×	68 0.3×	329 1.5×	327 1.5×	42	2.5k

Countries citing papers authored by Philip Poole‐Wilson

Since Specialization

Citations

This map shows the geographic impact of Philip Poole‐Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Poole‐Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Poole‐Wilson more than expected).

Fields of papers citing papers by Philip Poole‐Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Poole‐Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Poole‐Wilson. The network helps show where Philip Poole‐Wilson may publish in the future.

Co-authorship network of co-authors of Philip Poole‐Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Poole‐Wilson. A scholar is included among the top collaborators of Philip Poole‐Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Poole‐Wilson. Philip Poole‐Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hopkinson, Nicholas S, Mark Dayer, Sophie Antoine‐Jonville, et al.. (2012). Central and peripheral quadriceps fatigue in congestive heart failure. International Journal of Cardiology. 167(6). 2594–2599. 14 indexed citations

Assomull, Ravi, Carl Shakespeare, Paul R. Kalra, et al.. (2011). Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology. Circulation. 124(12). 1351–1360. 87 indexed citations

Cohen‐Solal, Alain, Dipak Kotecha, Dirk J. van Veldhuisen, et al.. (2009). Efficacy and Safety of Nebivolol in Elderly Heart Failure Patients with Impaired Renal Function: Insights from the SENIORS Trial. European Journal of Heart Failure. 11(9). 872–880. 77 indexed citations

Westaby, Stephen, Adrian Banning, Desley Neil, Philip Poole‐Wilson, & O.H. Frazier. (2009). Optimism derived from 7.5 years of continuous-flow circulatory support. Journal of Thoracic and Cardiovascular Surgery. 139(3). e45–e47. 9 indexed citations

Boman, Kurt, Jan‐Håkan Jansson, Torbjörn Nilsson, et al.. (2009). Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure - a COMET substudy. Thrombosis Research. 125(2). e46–e50. 5 indexed citations

Remme, Willem J., John G.F. Cleland, Leif Erhardt, et al.. (2007). Effect of Carvedilol and Metoprolol on the Mode of Death in Patients with Heart Failure. European Journal of Heart Failure. 9(11). 1128–1135. 29 indexed citations

Olsson, Lars, Karl Swedberg, John G.F. Cleland, et al.. (2007). Prognostic Importance of Plasma NT-Pro BNP in Chronic Heart Failure in Patients Treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) Trial. European Journal of Heart Failure. 9(8). 795–801. 60 indexed citations

Sandek, Anja, Juergen Bauditz, Alexander Swidsinski, et al.. (2007). Altered Intestinal Function in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 50(16). 1561–1569. 501 indexed citations breakdown →

Girling, Alan, G. H. Freeman, Jason Gordon, et al.. (2007). Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy. International Journal of Technology Assessment in Health Care. 23(2). 269–277. 26 indexed citations

10.

Salukhe, Tushar V., Dárrel P. Francis, Jonathan R. Clague, et al.. (2006). Mechanism of Cardiac Output Gain from Cardiac Resynchronization Therapy in Patients With Coronary Artery Disease or Idiopathic Dilated Cardiomyopathy. The American Journal of Cardiology. 97(9). 1358–1364. 10 indexed citations

11.

Ekman, Inger, Kurt Boman, Andrew Charlesworth, et al.. (2005). Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. Patient Education and Counseling. 61(3). 348–353. 56 indexed citations

12.

Komajda, Michel, Pablo Lapuerta, José Ramón González‐Juanatey, et al.. (2005). Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. European Heart Journal. 26(16). 1653–1659. 301 indexed citations

13.

Poole‐Wilson, Philip. (2005). The prevention of cardiovascular disease worldwide: whose task and WHO’s task?. Clinical Medicine. 5(4). 379–384. 15 indexed citations

14.

Salukhe, Tushar V., Dárrel P. Francis, Jonathan R. Clague, et al.. (2005). Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern. International Journal of Cardiology. 100(1). 5–12. 13 indexed citations

15.

Metra, Marco, Livio Dei, Andrea Di Lenarda, & Philip Poole‐Wilson. (2004). Beta-Blockers in Heart Failure: Are Pharmacological Differences Clinically Important?. Heart Failure Reviews. 9(2). 123–130. 35 indexed citations

16.

Gang, Yi, Takuya Ono, Katerina Hnatkova, et al.. (2003). QT Dispersion Has No Prognostic Value in Patients with Symptomatic Heart Failure: An ELITE II Substudy. Pacing and Clinical Electrophysiology. 26(1p2). 394–400. 29 indexed citations

17.

Poole‐Wilson, Philip, Barry F. Uretsky, Kristian Thygesen, et al.. (2002). eHEART: www.heartjnl.com. Heart. 89(1). 48–48. 1 indexed citations

18.

Adamopoulos, Stamatis, Piotr Ponikowski, Elena Cerquetani, et al.. (1998). Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. The American Journal of Cardiology. 82(7). 862–868. 27 indexed citations

19.

Burnstock, Geoffrey, et al.. (1993). Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine. Peptides. 14(2). 359–364. 8 indexed citations

20.

Bayliss, John, et al.. (1987). Acute Hemodynamic and Neuroendocrine Effects of Dopexamine, a New Vasodilator for the Treatment of Heart Failure. Journal of Cardiovascular Pharmacology. 9(5). 551–554. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact